Home / Inspections / 1294652

FDA Inspection 1294652 — Genzyme Corporation

Genzyme Corporation — FEI 1220423

The FDA completed an inspection of Genzyme Corporation on April 9, 2026 in Framingham, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 9, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Framingham, MA (United States)

Facility

Other inspections at this facility

  • 1232210 (OAI Tue Jul 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1176107 (VAI Mon Jul 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1003362 (NAI Thu Feb 02 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 904958 (VAI Fri Nov 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 897241 (VAI Thu Sep 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources